Netherlands· NL-2e7706c93765

Epirubicinehydrochloride Accord 2 mg/ml oplossing voor injectie of infusie

A epirubicin product containing epirubicinehydrochloride, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L01DB03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about epirubicinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Epirubicin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01DB03 (epirubicin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search epirubicin products by name

Epirubicin · ATC L01DB03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of epirubicin costs, country by country.

Normalised to the WHO defined daily dose (7 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Epirubicin · price per daily dose (7 mg)

USD · FX 28 Sept 2026

CH Switzerland$15.02

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EPIRUBICINEHYDROCHLORIDE
Manufacturer: Accord Healthcare B.V.
Country: Netherlands (NL)
ATC code: L01DB03
ATC class: Epirubicin
Defined daily dose: 7 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
100134

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

560 interactions on record for epirubicin.

Graded by severity as the source publishes them — 100 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check epirubicin against other medicines How interaction checks work

Epirubicin · interactions on record

560 records

100 severe
450 moderate
10 minor

Most severe, free to view

CimetidineA02BA01severe
PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Epirubicin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All epirubicin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Epirubicin Accord, Epirubicin Ebewe
Belgium · Epirubicin Ab, Epirubicin Eugia
Bulgaria · Епирубицин Ебеве, Еписиндан
Cyprus · Epirubicin Aqvida, Farmorubicin
Czechia · Epirubicin Accord, Epirubicin Teva
Germany · Bendaepi, Epi
Denmark · Epirubicin "medac", Epirubicin Accord
Estonia · Epirubicin Accord
Spain · Epirubicina Accord, Epirubicina Aurovitas
Finland · Epirubicin Accord, Epirubicin Ebewe
France · Epirubicine Accord, Epirubicine Hikma
United Kingdom (Northern Ireland) · Epirubicin, Epirubicin Hydrochloride Accord Healthcare
Greece · Epirubicin Hydrochloride Pharmachemie, Epirubicin Viatris
Hungary · Epirubicin Accord, Epirubicin Sandoz
Ireland · Epirubicin Hydrochloride Accord Healthcare Ireland, Epirubicin Seasec Pharmaceutical
Iceland · Epirubicin Actavis
Italy · Epirubicina Ahcl, Epirubicina Hikma
Lithuania · Epirubicin Accord
Luxembourg · Epirubicin Eugia, Epirubicine Teva
Latvia · Epirubicin Accord
Malta · Epirubicin Hydrochloride Accord Healthcare
Norway · Epirubicin Accord, Epirubicin Ebewe
Poland · Epirubicin Accord, Epirubicin Ebewe
Portugal · Epirrubicina Accord, Epirrubicina Adoh
Romania · Epirubicină Teva
Sweden · Epirubicin Accord, Epirubicin Ebewe
Slovenia · Epirubicin Ebewe, Epirubicin Teva
Slovakia · Epimedac, Epirubicín Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cadb2c29-eedb-4bce-8237-c1e466d00b06
GET /v1/drugs/cadb2c29-eedb-4bce-8237-c1e466d00b06?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie of infusie",
  "route": "Intraveneus gebruik, Intravesicaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h100134_smpc.pdf",
  "strength": null,
  "atc_label": "Epirubicin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg100134",
  "excipients": [
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "EPIRUBICINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h100134.pdf",
  "authorised_at": "2009/07/17",
  "procedure_number": "IE/H/0751/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "100134",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about epirubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console